种族与民族对肥厚型心肌病表现及结局的影响
该综述聚焦肥厚型心肌病(HCM)中基于种族和民族的差异,指出黑人HCM患者更常以心力衰竭就诊,但较少接受症状管理、心脏性猝死分层、室间隔心肌切除术或植入式心律转复除颤器。黑人患者院外心脏骤停后出院生存率较低,旁观者心肺复苏普及率也较低,亟需生物医学和社会干预及实施科学来减少差异。
要点
- 黑人HCM患者更常表现为心力衰竭,但较少接受改善生存的干预。
- 黑人患者旁观者心肺复苏率较低,院外心脏骤停后出院生存率较低。
- 亟需生物医学和社会干预及实施科学以减少基于民族的差异。
核心结论
- HCM的临床表现、管理和结局存在显著的种族和民族差异。
- 黑人HCM患者生存改善干预的使用较少且心脏骤停后生存率较低。
- 亟需生物医学和社会干预以及实施科学来减少差异。
研究设计与样本
- 综述(JACC焦点研讨会6/9),未报告系统检索策略或样本量。
主要发现
- 黑人HCM患者更常以心力衰竭就诊,但较少转诊进行症状管理、心脏性猝死分层、室间隔心肌切除术或植入式心律转复除颤器。
- 黑人患者旁观者心肺复苏普及率低于白人患者。
- 黑人HCM患者院外心脏骤停后出院生存率降低。
临床怎么用
- 临床中应关注HCM诊疗过程中的种族和民族差异,促进公平使用改善生存的干预。
- 需推动实施科学以支持在黑人患者和社区中持久采用循证疗法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Significant racial and ethnicity-based disparities in clinical presentation, management, and outcome of hypertrophic cardiomyopathy (HCM) are reported. Black patients with HCM are more likely to present with heart failure but are less commonly referred for symptom management, sudden cardiac death stratification, surgical septal myectomy, or for implantable cardioverter-defibrillators, all interventions that increase survival. Prevalence of bystander cardiopulmonary resuscitation is lower for Black patients than for White patients. Black patients with HCM have decreased survival after hospital discharge following out-of-hospital cardiac arrest. Biomedical and social interventions are urgently needed to reduce ethnicity-based disparities, which have an impact on outcomes in HCM and other cardiovascular diseases. There is also a need to focus on implementation science to support durable adoption of evidence-based therapies in Black patients and communities.
引用
- Ntusi NAB, Sliwa K. Associations of Race and Ethnicity With Presentation and Outcomes of Hypertrophic Cardiomyopathy: JACC Focus Seminar 6/9. J Am Coll Cardiol. 2021. PMID: 34887143. doi:10.1016/j.jacc.2021.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。